唾液中的 Bacteroides fragilis:调查与性结肠炎的联系
Samin Zamani1,2, Sima Besharat3, Nasser Behnampour4
1Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
概括
肠毒性细菌菌 (ETBF) 在性结肠炎 (UC) 患者中明显更常见.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 人类健康 人类健康 人类健康
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,病因不明.
- 新兴的研究表明,肠道微生物群,特别是肠毒性细菌 (ETBF),在UC的病变发生过程中.
- 这项研究调查了UC患者和健康对照 (HCs) 唾液中的Bacteroides fragilis (B. fragilis) 和ETF的存在.
研究的目的:
- 确定患有UC和没有UC的个体的唾液中的B. fragilis和ETBF的流行率和量化.
- 探索B. fragilis,ETBF和UC之间的潜在关联.
- 检查与UC相关的细菌存在的性别特异性差异.
主要方法:
- 从40名UC患者和40名HC患者收集了唾液样本.
- 实时聚合酶链反应 (PCR) 用于检测和量化B. fragilis和ETBF.
- 进行了统计分析,以比较不同组之间的细菌患病率和数量.
主要成果:
- 与HC相比,ETBF在UC患者中明显更为普遍 (50%与10%相比),并且在UC患者中更为丰富 (p < 0.0001).
- 在UC患者 (67.5%) 和HC患者 (70%) (p = 0.809) 之间,B. fragilis的患病率没有显著差异.
- 与没有UC的女性相比,UC的女性观察到显著更高的ETBF水平 (p = 0.000458).
结论:
- 这些发现表明ETBF在性结肠炎的发展或进展中可能发挥作用.
- 唾液ETBF可以作为UC的潜在生物标志物.
- 需要进一步的研究,以阐明将ETBF与UC联系起来的机制,并探索治疗策略.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Serum Laboratory Studies, Stool Test, Breath Test
324
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
324
What is Monogastric Digestion?
70.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.9K
Drugs for Treatment of Ulcerative Colitis in IBD
131
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
131
Chronic Bowel Disorders: Introduction
427
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427


